Laser diverticulotomy for Zenker's diverticulum-does it improve quality of life?

To determine quality of life (QoL) in individuals with dysphagia related to identified Zenker’s diverticulum before (T1) and one year after undergoing endoscopic laser diverticulotomy surgery (T2). A total of 43 individuals (18 women and 25 men) were included at T1 and 37 of these responded at T2 (13 women and 24 men). Health-related QoL (HRQoL) was determined with the short form 36 (SF-36) and disease-specific QoL (DSQoL) was assessed with the MD Anderson Dysphagia Inventory (MDADI). In addition, two questions about specific symptoms related to Zenker’s diverticulum were added and ordered as a fifth subscale of MDADI. Comparisons were made between patients and an age- and gender-adjusted normative sample from the Norwegian population. Significant differences were found in all subscales on MDADI, but none between T1 and T2 on SF-36. Compared to the normative sample, the component score MCS of SF-36 was significantly lower in the dysphagia patients at both T1 and T2. The attrition sample had significantly lower PCS than the completers. The results substantiate that disease severity is associated with poorer disease-related QoL, and that the disease-specific QoL is significantly improved one year after laser diverticulotomy

From the clavicle to the windpipe: Tracheal window resections reconstructed with calcifying periosteum in thyroid cancer

Objectives We aimed to evaluate the outcomes of tracheal window resection and reconstruction using a vascularized periosteal flap (intended for calcification) harvested from the medial clavicle. This is one of several surgical techniques for tracheal resection and reconstruction used for patients with thyroid carcinoma invading the trachea. Importantly, in partial tracheal resection postoperative dynamic airway collapse must be prevented. Reconstruction of the tracheal defect with a vascularized periosteal flap is one method of achieving a stable airway. Methods Twelve patients with locally advanced thyroid carcinoma who underwent tracheal resection and reconstruction at Oslo University Hospital from 2004 to 2017 were studied retrospectively. The primary outcome was a stable airway not requiring airway stenting. The secondary outcomes were the time to decannulation, morbidity, and survival. Results Eleven of 12 patients did not require airway stenting postoperatively after a median of 111 days. Seven patients developed postoperative complications. The median observation time was 74.8 months (range 10.5‐153.5) for all patients. The median disease‐free survival was 40 months (range 0‐147). By February 1, 2020, seven patients were alive, of whom five showed no evidence of disease. Conclusions Tracheal reconstruction with a vascularized periosteal flap yielded good results in terms of establishing a stable airway. This procedure is a viable reconstructive option that allows for decannulation by preventing airway collapse, thereby potentially mitigating the need for end‐to‐end (ETE) anastomosis or sleeve resections. For selected patients, this procedure may prevent local fatal complications from thyroid cancer invading the trachea. Level of evidence Level 4

Laser diverticulotomy for Zenker's diverticulum-does it improve quality of life?

To determine quality of life (QoL) in individuals with dysphagia related to identified Zenker’s diverticulum before (T1) and one year after undergoing endoscopic laser diverticulotomy surgery (T2). A total of 43 individuals (18 women and 25 men) were included at T1 and 37 of these responded at T2 (13 women and 24 men). Health-related QoL (HRQoL) was determined with the short form 36 (SF-36) and disease-specific QoL (DSQoL) was assessed with the MD Anderson Dysphagia Inventory (MDADI). In addition, two questions about specific symptoms related to Zenker’s diverticulum were added and ordered as a fifth subscale of MDADI. Comparisons were made between patients and an age- and gender-adjusted normative sample from the Norwegian population. Significant differences were found in all subscales on MDADI, but none between T1 and T2 on SF-36. Compared to the normative sample, the component score MCS of SF-36 was significantly lower in the dysphagia patients at both T1 and T2. The attrition sample had significantly lower PCS than the completers. The results substantiate that disease severity is associated with poorer disease-related QoL, and that the disease-specific QoL is significantly improved one year after laser diverticulotomy

Impact of stage, management and recurrence on survival rates in laryngeal cancer.

A retrospective, longitudinal study of 1,616 patients with primary laryngeal squamous cell carcinoma (LSCC) at a single center in Norway during 1983-2010 was undertaken to investigate overall survival, disease specific survival, disease-free survival, prognostic factors for overall survival, and impact of recurrence among all-stage laryngeal cancer patients over 15 years' follow-up. The prognostic impact of gender, age, smoking/alcohol, subsite, tumour, node and metastasis staging, period and modality of treatment were evaluated using Kaplan-Meier and Cox proportional hazard analyses. The importance of recurrence on survival was assessed based on case fatality rates. Five-year overall survival was 56.8%, 64.0% and 38.8%, and disease-specific survival was 80.2%, 87% and 61.6%, respectively, for the entire cohort and for glottic and supraglottic LSCC. Old age, advanced-stage LSCC and supraglottic cancer were associated with lower overall survival. The risk of disease-specific death plateaued after five years and varied significantly by subsite. Multivariate analysis of glottic LSCC revealed that surgical treatment improved overall survival, whereas old age, alcohol, T3-T4 status, positive N-status and no treatment were associated with worse survival. In supraglottic LSCC, age, alcohol, and positive N-status had a significant impact on overall survival by multivariate analysis. Five-year overall survival and disease-specific survival among patients with recurrent disease were 34% and 52%, respectively. In conclusion, marked difference in overall survival between glottic and supraglottic LSCC underline the importance of subsite-specific survival analysis. T-status and primary surgical management is essential only for glottic LSCC, emphasizing the importance of correct disease classification. Inferior outcomes in supraglottic LSCC are associated with old age, positive N-status, and improved follow-up routines are necessary. Primary tumor control is essential since recurrence impairs survival considerably in all subsites. The potential benefit of a primary surgical approach towards T3 LSCC awaits further investigation

Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles.

In this cohort study we examined whether gender, age at onset, observation time or human papillomavirus (HPV) genotype are risk factors for an aggressive clinical course in Recurrent Respiratory Papillomatosis (RRP). Clinical data from patient records comprised gender, age at onset, date of first endolaryngeal procedure with biopsy, date of last follow-up, total number of endolaryngeal procedures, and complications during the observation period. Disease was defined as juvenile (JoRRP) or adult onset (AoRRP) according to whether the disease was acquired before or after the age of 18. Aggressive disease was defined as distal spread, tracheostomy, four surgical operations annually or >10 surgeries in total. DNA was extracted from formalin-fixed paraffin-embedded tissue. HPV genotyping was performed by quantitative PCR assay identifying 15 HPV genotypes. The study included 224 patients. The majority were males (141/174 in AoRRPs and 31/50 in JoRRPs; p = 0.005). The median follow-up from initial diagnosis was 12.0 years (IQR 3.7-32.9) for JoRRPs and 4.0 years (IQR 0.8-11.7) for AoRRPs. The disease was more aggressive in juveniles than adults (p<0.001), a difference that disappeared after 10 years' observation. JoRRPs with aggressive disease were younger at onset (mean difference 4.6 years, 95%CI [2.4, 6.8], p = 0.009). HPV6 or -11 was present in all HPV-positive papillomas. HPV11 was more prevalent in aggressive disease, and HPV6 in non-aggressive disease (p<0.001). Multiple logistic regression revealed that only age at onset (OR = 0.69, 95% CI [0.53, 0.88], p = 0.003) was associated with aggressive disease in juveniles, while HPV11 (OR = 3.74, 95% CI [1.40, 9.97], p = 0.008) and observation time >10 years (OR = 13.41, 95% CI [5.46, 32.99[, p<001) were risk factors in adults. In conclusion, the only significant risk factor for developing aggressive disease in JoRRPs was age at onset, but both HPV11 and observation time >10 years were risk factors for an aggressive disease course in AoRRPs

Risk of recurrence in laryngeal cancer

A cohort study was undertaken to analyze the risk of recurrence among 1616 patients with primary squamous cell carcinoma of the larynx from 1983 to 2010 at a single, tertiary academic center in Oslo, Norway. The cohort was followed from the date of diagnosis to September 2011. Competing risk regression analysis assessed the association between various risk factors and the risk of recurrence, where death was considered a competing event. Recurrence was observed in 368 patients (23%) during the study period. The majority (71%) of recurrences involved the location of the primary tumor. The overall risk of recurrence during the first three years after initiating treatment was 20.5%. Increased risk of recurrence was observed in patients with supraglottic cancer, younger patients, those with T2–T3 tumors and in patients treated in the earlier part of the study period. Significant factors for recurrence in glottic carcinomas were age, treatment in the earlier part of the study and T-status, whereas age was a significant factor in supraglottic cancer. N-status appeared less significant. In conclusion, follow-up of laryngeal squamous cell carcinoma should place particular emphasis on the site of the primary tumor, younger patients, cases of supraglottic cancer and T2-T4 primary tumors, especially during the first three years after treatment. More studies are needed to assess the impact of surgical versus non-surgical treatment, and eventually the significance of recurrence, for disease-specific and overall survival in cases of advanced laryngeal squamous cell carcinoma

Overall survival of early-stage and advanced-stage supraglottic LSCC according to non-surgical and surgical treatment.

<p>Overall survival of early-stage and advanced-stage supraglottic LSCC according to non-surgical and surgical treatment.</p

Overall survival of 1,616 LSCC patients according to subsite during 15 years' follow-up.

<p>Overall survival of 1,616 LSCC patients according to subsite during 15 years' follow-up.</p